Mounjaro
The latest news about Mounjaro: headlines, AI summaries and the full story from every source.
- Eli Lilly's Upcoming Earnings Report and the Significance of Retatrutide
- Eli Lilly Announces Promising Weight Loss Drug Combination
- Eli Lilly Halts Development of an Obesity Drug Amid High Standards and Strategic Diversification
- Eli Lilly's Momentum Faces Potential Threat from Competitive GLP-1 Market
- Eli Lilly's Supply Constraints and Market Impact
- Eli Lilly's Weight-Loss Drug Revenue Grows Despite Decline in GLP-1 Insurance Coverage
- Ken Griffin Increases Stake in Eli Lilly Amid Strong Performance
- Eli Lilly's Weight-Loss and Diabetes Drugs Contribute Over Two-Thirds of Q1 Revenue
- Rising Use of GLP-1 Drugs Benefits Eli Lilly
- Eli Lilly's GLP-1 Drugs Face Potential Coverage Reduction by Employers
- Eli Lilly Aims to Leverage GLP-1 Success for Future Acquisitions
- Eli Lilly's Continued Growth Driven by GLP-1 Expansion and Strategic Acquisitions
- Eli Lilly Reports Strong Q1 Earnings and Raises Full-Year Guidance Amid Mounjaro Growth
- Eli Lilly's Mounjaro Becomes the World's Best-Selling Drug
- Eli Lilly Announces Positive News for Shareholders Amid Weight Loss Drug Market Growth
- Eli Lilly's GLP-1 Drugs Drive Revenue Growth, With Potential for Further Expansion
- Eli Lilly Reports Strong Earnings Growth Driven by Weight Loss Drugs
- Eli Lilly Reports 56% Revenue Surge Amid Strong Demand for GLP-1 Drugs
- Eli Lilly Raises Annual Profit Forecast Due to Strong Demand for GLP-1 Drugs
- Eli Lilly to Report First-Quarter Earnings Ahead of Market Open